Novo Nordisk A/S shares slid on Friday as a US rival’s comments on an experimental obesity drug gave rise to concerns about potential new competition in the rapidly growing space.
Brazil Succumbs to the Retail Apocalypse It Staved Off for YearsDanske’s Net Income Rises 9% Helped by Higher Interest RatesSoft US Jobs Raise Selloff Risk for Stocks, BofA Strategist Hartnett SaysThe Lights Are On in South Africa and Many People Are SuspiciousECB Isn’t Pre-Committing to a Particular Rate Path, Lane SaysKraken Unit Quietly Claims Pivotal Position in Bitcoin ETF BoomUber Rival Bolt Raises €220 Million in Credit to Gear Up for IPOGabon Hires Citigroup for Investor Meetings as...
Here's how to reduce your premiumsBenefits await gig workers who come clean with CRASick of extra fees online? It's drip pricing, and Canadian shoppers are fighting backHome ownership essential for a workable retirement plan: Dale JacksonDon't let the new car smell go to your head when borrowing to buy a carWhat do young adults need to know about their taxes this year?'Like throwing money down the drain': Food waste is out as grocery prices rise and budgets tightenQatari...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Amgen Soars as CEO Gives Update on Experimental Obesity Drug(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s...
Read more »
Amgen Soars After CEO Gives Update on Experimental Obesity DrugAmgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide.
Read more »
Novo Nordisk slides while Moderna pops: Tale of two pharma stocksPharmaceutical stocks Novo Nordisk (NVO) and Moderna (MRNA) are trending in opposite directions following their earnings reports. Despite topping Wall...
Read more »
Amgen, DraftKings, Live Nation: Trending tickersShares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology...
Read more »
Amgen investors await weight-loss drug dataExplore stories from Atlantic Canada.
Read more »
Intel slides as foundry business loss spotlights wide gap with rival TSMCExplore stories from Atlantic Canada.
Read more »